Prestige BioPharma Limited (950210.KS) KSC
7,140.00
+610(+9.34%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 883.41B |
| Enterprise Value | 912.21B |
| P/E Ratio | -7.46 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 26.46 |
| Price/Book Ratio | 0.9 |
| Enterprise/Revenue | 27.86 |
| Enterprise/EBITDA | -10.28 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -3.55 |
| Operating Margin | -5.22 |
Management Effectiveness
| Return On Assets | -0.07 |
| Return On Equity | -0.14 |
Income Statement
| Revenue | 14.31B |
| Revenue/Share | 269.85 |
| Gross Profit | -24.01B |
| EBITDA | 33.31B |
| Net Income | 22.27B |
| Diluted EPS | 370.61 |
Balance Sheet
| Total Cash | 64.19B |
| Total Cash/Share | 1,068.16 |
| Total Debt | 86.98B |
| Total Debt/Equity | 0.18 |
| Current Ratio | 0.85 |
| Book Value Per Share | 9,341.16 |
Price History
| 52-Week Change | -46.19 |
| 52-Week High | 20,000 |
| 52-Week Low | 6,200 |
| Moving Average 50 Days | 8,757.6 |
| Moving Average 200 Days | 11,602.5 |
Statistics
| Average Volume | 102,351 |
| Shares Outstanding | 60.1M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
